Clinical Trial Update: Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel

View source ↗

Summary

A completed clinical trial evaluating a new oral contrast agent for MR enterography to assess Crohn disease in the small bowel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Mayo Clinic | Conditions: Crohn Disease | Status: COMPLETED